AI assistant
Sending…
Crinetics Pharmaceuticals, Inc. — Director's Dealing 2018
Jul 18, 2018
31156_dirs_2018-07-17_43843a58-d995-48b5-8e5e-652ee4b83828.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Crinetics Pharmaceuticals, Inc. (CRNX)
CIK: 0001658247
Period of Report: 2018-07-17
Reporting Person: Nielsen Jack (Director)
More from Crinetics Pharmaceuticals, Inc.
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25